Category: Lasers

Palomar's losses surge 600 percent

July 29, 2010 by MassDevice staff

Palomar Medical Technologies Inc. (NSDQ:PMTI) Q2 losses surged some 600 percent as it invested heavily in infrastructure costs.

The cosmetic laser surgery equipment-maker reported $1.7 million in net losses, or 9 cents per diluted share, on $15.6 million in sales during the three months ended June 30. A dramatic increase compared to a net loss of $243,922, at 1 cent per diluted share, on revenue of $15.0 million during the same period last year.

Elemé Medical reels in nearly $7 million

July 19, 2010 by MassDevice staff

Elemé Medical Inc. added $6.6 million to its coffers in a debt offering, according to a regulatory filing.

The Merrimack, N.H.-based cosmetic device maker raised the cash from nine un-named investors, according to the filing.

Monteris Medical drums up $3.4 million for brain tumor laser treatment

June 22, 2010 by MedCity News

By Brandon Glenn

Monteris Medical Inc. raised $3.4 million in an equity round for a device that enables minimally invasive laser surgery for brain tumors, according to a regulatory filing.

Monteris hopes to stretch the funding round to about $4.5 million, CEO Jim Duncan said. The 25-employee company has garnered $21 million in investment funding since its 1999 inception.

Cynosure wins approvals in three international markets

May 18, 2010 by MassDevice staff

Cynosure Inc. (NSDQ:CYNO) got the green light to market laser hair removal devices and a liposuction device in Asia and South America.

The Westford, Mass.-based cosmetic surgery device maker said its Elite MPX was approved by the Food and Drug Administration of Korea. Meanwhile, the company's Elite Aesthetic Workstation was awarded marketing authorization by Colombia's National Institute of Food and Drug Monitoring.

And Hong Kong's Dept. of Health gave approval to Cynosure's laser liposuction device, the Smartlipo MPX.

Cynosure's Q1 sales rise, net losses narrow

May 4, 2010 by MassDevice staff

Cynosure Inc. (NSDQ:CYNO) posted first-quarter revenues of $18.8 million, a gain of 27.5 percent over the $14.8 million it reported during Q1 2009, and narrowed its net losses 30.1 percent.

The Westford, Mass. based cosmetic laser surgery device maker reported net losses of $2.8 million, or 22 cents per share, during the three months ended March 31, turning a corner from $4.0 million, or 32 cents per share, during the same period last year.

Palomar's Q1 sales rise, losses widen

April 29, 2010 by MassDevice staff

Palomar Medical Technologies Inc. (NSDQ:PMTI) posted a 9.2 percent increase in first-quarter sales, but saw its net losses yawn by 77 percent.

The Burlington, Mass.-based cosmetic device maker posted sales of $16.0 million during the three months ended March 31, compared with $14.6 million during the same period last year.

Net losses were $2.5 million, or 14 cents per diluted share, compared with $1.4 million, or 8 cents per diluted share, during Q1 2009.